Has Justin Bryant, DO received payments from drug or device companies?

Yes. Drug and device makers reported $3,518 in general payments to Justin Bryant, DO across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Justin Bryant, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Justin Bryant, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Justin Bryant, DO

Plastic and Reconstructive Surgery · Fort Wayne, INNPI 1427363449

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Stryker at 33.3% of the total. Reporting peaked in 2024 at $1,217 and has fallen 58.9% since, to $500 in 2025.

$3,518in general payments, 2019–2025

Across 31 payments — averaging $113.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$1K
Axogen$369
Medical Device Business Services, Inc.$350
E.r. Squibb & Sons, L.L.C.$342
Integra Lifesciences Corporation$326
Mentor Worldwide LLC$237
plus $723 from 7 others

What the payments were for

Travel & lodging$1,19034%
Food & beverage$1,97856%
Education$35010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	2	$1,171
Axogen	2	$369
Medical Device Business Services, Inc.	1	$350
E.r. Squibb & Sons, L.L.C.	2	$342
Integra Lifesciences Corporation	2	$326
Mentor Worldwide LLC	5	$237
Smith+Nephew	9	$185
Johnson & Johnson	1	$147
TELA Bio, Inc.	2	$135
Merck	1	$114
Musculoskeletal Transplant Foundation Inc.	2	$65
KCI USA, Inc.	1	$52
AbbVie	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

1788$926
CYTAL$359
SPY-PHI SYSTEM$245
AVANCE NERVE GRAFT$234
TRUMATCH$147
INTEGRA MESHED BILAYER WOUND MATRIX$147
INTEGRA WOUND MATRIX (IWM)$147
PRIMATRIX$147
INTEGRA DERMAL REGENERATION TEMPLATE$147
INTEGRA FLOWABLE WOUND MATRIX$147
Sotyktu$122
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$120
KEYTRUDA$114
MENTOR MemoryGel Resterilizable Gel Sizer$108

How this compares

$3,518 in reported general payments places this provider in the 65th percentile of 47 plastic and reconstructive surgery providers in Indiana.

See all plastic and reconstructive surgery providers in Indiana →

Medicare billing

Part B allowed, 2024

$56,409

Medicare patients

Services billed

182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	23	$177
Methocarbamol	50	$158
CefuroximeCefuroxime Axetil	11	$106
Oxycodone Hcl	59	$75
Tizanidine Hcl	13	$16

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Fort Wayne

Evan WestrickFort Wayne$2K
Aladdin HassaneinIndianapolis$103K
Leigh SperaIndianapolis$16K
Janet TurkleCarmel$15K
Dion ChavisIndianapolis$15K
David RobinsonMunster$9K
James ConkrightNewburgh$8K
Christopher JonesIndianapolis$7K
Erin WeberIndianapolis$7K
Samual FullerSouth Bend$7K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →